Ocular Therapeutix logo

Ocular Therapeutix Share Price Today

(NASDAQ: OCUL)

Ocular Therapeutix share price is $7.31 & ₹624.75 as on 18 Apr 2025, 2.30 'hrs' IST

$7.31

0.14

(1.95%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Ocular Therapeutix share price in Dollar and Rupees. Guide to invest in Ocular Therapeutix stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Ocular Therapeutix, along with analyst recommendations, forecasts, and comprehensive financials.

Ocular Therapeutix share price movements

  • Today's Low: $7.12
    Today's High: $7.38

    Day's Volatility :3.52%

  • 52 Weeks Low: $4.06
    52 Weeks High: $11.78

    52 Weeks Volatility :65.52%

Ocular Therapeutix (OCUL) Returns

PeriodOcular Therapeutix IncSector (Health Care)Index (Russel 2000)
3 Months
-9.64%
-2.8%
0.0%
6 Months
-35.71%
-11.0%
0.0%
1 Year
40.04%
-1.9%
0.0%
3 Years
95.45%
-1.5%
-12.9%

Ocular Therapeutix (OCUL) Key Statistics

in dollars & INR

Previous Close
$7.17
Open
$7.16
Today's High
$7.38
Today's Low
$7.12
Market Capitalization
$1.2B
Today's Volume
$1.6M
52 Week High
$11.775
52 Week Low
$4.06
Revenue TTM
$63.7M
EBITDA
$-169.6M
Earnings Per Share (EPS)
$-1.22
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-95.21%

How to invest in Ocular Therapeutix Stock (OCUL) from India?

It is very easy for Indian residents to invest directly in Ocular Therapeutix from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ocular Therapeutix stock in both Indian Rupees (INR) and US Dollars (USD). Search for Ocular Therapeutix or OCUL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ocular Therapeutix or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ocular Therapeutix shares which would translate to 0.117 fractional shares of Ocular Therapeutix as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Ocular Therapeutix, in just a few clicks!

Returns in Ocular Therapeutix (OCUL) for Indian investors in Rupees

The Ocular Therapeutix stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ocular Therapeutix investment value today

Current value as on today

₹1,42,379

Returns

₹42,379

(+42.38%)

Returns from Ocular Therapeutix Stock

₹40,038 (+40.04%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Ocular Therapeutix (OCUL)

-82%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Ocular Therapeutix Stock from India on INDmoney has decreased by -82% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Ocular Therapeutix

  • SUMMER ROAD LLC

    8.72%

  • Deep Track Capital, LP

    8.07%

  • VR Adviser, LLC

    8.03%

  • BlackRock Inc

    7.45%

  • Vanguard Group Inc

    5.34%

  • venBio Select Advisor LLC

    5.07%

Analyst Recommendation on Ocular Therapeutix

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Ocular Therapeutix(by analysts ranked 0 to 5 stars)

Analyst Forecast on Ocular Therapeutix Stock (OCUL)

What analysts predicted

Upside of 139.4%

Target:

$17.50

Current:

$7.31

Insights on Ocular Therapeutix Stock (Ticker Symbol: OCUL)

  • Price Movement

    In the last 3 years, OCUL stock has moved up by 80.2%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 15.42M → 17.08M (in $), with an average increase of 9.7% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -36.49M → -48.38M (in $), with an average decrease of 32.6% per quarter
  • OCUL vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 38.7%
  • Price to Sales

    ForOCUL every $1 of sales, investors are willing to pay $18.1, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Ocular Therapeutix Technicals Summary

Sell

Neutral

Buy

Ocular Therapeutix is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Ocular Therapeutix (OCUL) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Ocular Therapeutix Inc logo
-3.63%
-35.71%
40.04%
95.45%
38.71%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Ocular Therapeutix

Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing AXPAXLI, an axitinib intravitreal hydrogel that is in phase 3 clinical trials for the treatment of wet age-related macular degeneration and in Phase 1 clinical trials for the treatment of non-proliferative diabetic retinopathy; PAXTRAVA, a travoprost intracameral hydrogel, which is in phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension. The company has a license agreement and collaboration with AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and PAXTRAVA. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.
Organization
Ocular Therapeutix
Employees
274
CEO
Dr. Pravin U. Dugel M.D.
Industry
Health Technology

Management People of Ocular Therapeutix

NameTitle
Mr. Donald Notman Jr.
CFO, COO & Principal Accounting Officer
Dr. Jeffrey S. Heier M.D.
Chief Scientific Officer
Dr. Pravin U. Dugel M.D.
Executive Chairman, President & CEO
Dr. Peter K. Jarrett Ph.D.
Chief Technology Officer
Mr. William S. Slattery Jr.
Vice President of Investor Relations
Mr. Todd D.C. Anderman J.D.
Chief Legal Officer & Corporate Secretary
Mr. William H. Ransone II
Vice President of Global Sales & Marketing
Mr. Barry Rubenstein M.S.
Chief Human Resources Officer
Mr. Steve Meyers
Chief Commercial Officer
Dr. Peter K. Kaiser M.D.
Chief Development Officer

Important FAQs about investing in OCUL Stock from India :

What is Ocular Therapeutix share price today?

Ocular Therapeutix share price today stands at $7.31, Open: $7.16 ; Previous Close: $7.17 ; High: $7.38 ; Low: $7.12 ; 52 Week High: $11.78 ; 52 Week Low: $4.06.

The stock opens at $7.16, after a previous close of $7.17. The stock reached a daily high of $7.38 and a low of $7.12, with a 52-week high of $11.78 and a 52-week low of $4.06.

Can Indians buy Ocular Therapeutix shares?

Yes, Indians can invest in the Ocular Therapeutix (OCUL) from India.

With INDmoney, you can buy Ocular Therapeutix at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Ocular Therapeutix at zero transaction cost.

How can I buy Ocular Therapeutix shares from India?

It is very easy to buy Ocular Therapeutix from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ocular Therapeutix (OCUL) be purchased?

Yes, you can buy fractional shares of Ocular Therapeutix with INDmoney app.

What are the documents required to start investing in Ocular Therapeutix stocks?

To start investing in Ocular Therapeutix, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Ocular Therapeutix Stock (OCUL)?

Today’s highest price of Ocular Therapeutix (OCUL) is $7.38.

Today’s lowest price of Ocular Therapeutix (OCUL) is $7.12.

What is today's market capitalisation of Ocular Therapeutix?

Today's market capitalisation of Ocular Therapeutix OCUL is 1.2B

What is the 52 Week High and Low Range of Ocular Therapeutix Stock (OCUL)?

  • 52 Week High

    $11.78

  • 52 Week Low

    $4.06

What are the historical returns of Ocular Therapeutix (OCUL)?

  • 1 Month Returns

    -3.63%

  • 3 Months Returns

    -35.71%

  • 1 Year Returns

    40.04%

  • 5 Years Returns

    38.71%

Who is the Chief Executive Officer (CEO) of Ocular Therapeutix ?

Dr. Pravin U. Dugel M.D. is the current Chief Executive Officer (CEO) of Ocular Therapeutix.